Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Cancers
|
December 30, 2014
p53 Acetylation: Regulation and Consequences
Sara M Reed, Dawn E Quelle
Cell Cycle (Georgetown, Tex.)
|
April 24, 2014
ARF sees Pdgfrβ through the miR
Sara M Reed, Frederick W Quelle, Dawn E Quelle
Cell Cycle (Georgetown, Tex.)
|
March 14, 2014
Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53
Sara M Reed, Jussara Hagen, Van S Tompkins, et al.
International Journal of Molecular Sciences
|
December 17, 2024
Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death
Raja Gopal Reddy Mooli, Dhanunjay Mukhi, Mikayla Watt, et al.
Genes & Cancer
|
October 30, 2013
RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients
Viviane P Muniz, Ryan W Askeland, Xuefeng Zhang, et al.
Plos One
|
November 14, 2014
NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomas
Sara M Reed, Jussara Hagen, Viviane P Muniz, et al.
Cancer Research
|
October 3, 2014
RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner
Jussara Hagen, Viviane P Muniz, Kelly C Falls, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Cancers
|
December 30, 2014
p53 Acetylation: Regulation and Consequences
Sara M Reed, Dawn E Quelle
Cell Cycle (Georgetown, Tex.)
|
April 24, 2014
ARF sees Pdgfrβ through the miR
Sara M Reed, Frederick W Quelle, Dawn E Quelle
Cell Cycle (Georgetown, Tex.)
|
March 14, 2014
Nuclear interactor of ARF and Mdm2 regulates multiple pathways to activate p53
Sara M Reed, Jussara Hagen, Van S Tompkins, et al.
International Journal of Molecular Sciences
|
December 17, 2024
Hypoxia-Inducible Factor-2α Promotes Liver Fibrosis by Inducing Hepatocellular Death
Raja Gopal Reddy Mooli, Dhanunjay Mukhi, Mikayla Watt, et al.
Genes & Cancer
|
October 30, 2013
RABL6A Promotes Oxaliplatin Resistance in Tumor Cells and Is a New Marker of Survival for Resected Pancreatic Ductal Adenocarcinoma Patients
Viviane P Muniz, Ryan W Askeland, Xuefeng Zhang, et al.
Plos One
|
November 14, 2014
NIAM-deficient mice are predisposed to the development of proliferative lesions including B-cell lymphomas
Sara M Reed, Jussara Hagen, Viviane P Muniz, et al.
Cancer Research
|
October 3, 2014
RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner
Jussara Hagen, Viviane P Muniz, Kelly C Falls, et al.
Page
of 1